|1.||Parada, C A: 3 articles (01/2015 - 03/2007)|
|2.||Yamaya, Mutsuo: 3 articles (07/2014 - 01/2011)|
|3.||Nishimura, Hidekazu: 3 articles (07/2014 - 01/2011)|
|4.||Kubo, Hiroshi: 3 articles (07/2014 - 01/2011)|
|5.||Maestroni, Georges J M: 3 articles (04/2008 - 11/2003)|
|6.||Teixeira, J M: 2 articles (01/2015 - 09/2014)|
|7.||Tambeli, C H: 2 articles (09/2014 - 03/2007)|
|8.||Nadine, Lusamba: 2 articles (07/2014 - 08/2013)|
|9.||Nagatomi, Ryoichi: 2 articles (07/2014 - 01/2011)|
|10.||Yu, Le: 2 articles (06/2011 - 06/2007)|
03/01/1990 - "However, the pressor response to the stressors was greater in ICI 118,551- than vehicle-treated F1, but the tachycardia was equivalent for both groups. "
12/01/1987 - "3. When compared with the effect of placebo, propranolol reduced blood pressure and exercise heart rate whereas ICI 118551 had no significant effect on blood pressure and produced a small but significant reduction in exercise-induced tachycardia. "
04/01/2003 - "In TG4 right atria, however, (-)-CGP 12177-evoked tachycardia was resistant to blockade by CGP 20712A but antagonised by ICI 118,551, consistent with mediation through human beta(2)-adrenoceptors. "
06/01/2000 - "In the presence of the beta(2)-adrenoceptor antagonist, ICI 118551, a hindquarters vasoconstrictor response to human leptin was not seen, and there was a tachycardia, as there was to murine leptin. "
09/01/1990 - "The selective beta 2-adrenoceptor antagonist ICI 118,551 (3 mg/kg, s.c.) prevented the tachycardia but not the increase in PRC caused by 100 micrograms/kg pindolol. "
12/01/2011 - "In OIR mice, ICI 118,551 is effective in increasing electroretinographic responses suggesting that activation of β(2) -ARs constitutes an important part of the retinal response to hypoxia. "
12/01/2011 - "In addition, the specificity of ICI 118,551 on retinal angiogenesis has been demonstrated by the finding that in mouse retinal explants, β(2) -AR silencing prevents ICI 118,551 effects on hypoxia-induced vascular endothelial growth factor accumulation. "
02/01/1991 - "The response to ventilatory hypoxia was enhanced by propranolol or ICI 118551, suggesting that the response is modulated by circulating catecholamines that are probably of adrenal origin. "
01/01/1985 - "At 1 day of age, either phenoxybenzamine or ICI-118551, but not atenolol, shortened the survival time during hypoxia. "
12/24/1984 - "Propranolol, atenolol and ICI 118,551 each abolished the enhancement of chemoreceptor activity produced by i.v. infusion of exogenous isoproterenol; however, the blocking drugs did not significantly diminish the increase in chemoreceptor neural discharge induced by hypoxia. "
|3.||Essential Tremor (Essential Tremors)
12/01/1987 - "4. ICI 118551 may be useful in the management of essential tremor while having fewer cardiovascular side-effects than non-selective beta-adrenoceptor antagonists."
12/01/1987 - "2. ICI 118551 (150 mg daily for 7 days) and propranolol (120 mg daily for 7 days) were about equally effective in reducing essential tremor (by about 40%) and were more effective than placebo. "
12/01/1987 - "1. The effects of the selective beta 2-adrenoceptor antagonist ICI 118551 on essential tremor, heart rate and blood pressure were compared with those of propranolol. "
12/01/1987 - "The comparative effects of ICI 118551 and propranolol on essential tremor."
|5.||Hypertension (High Blood Pressure)
12/01/1985 - "To test this hypothesis we performed a double-blind placebo controlled crossover study in nine patients with mild hypertension, comparing the effects of the beta 2-selective blocker ICI 118,551, 50 mg t.i.d. "
02/01/1987 - "We then performed a double-blind, placebo-controlled trial in patients with mild essential hypertension to compare this compound with propranolol, 80 mg t.i.d., and showed that ICI 118551 significantly decreased systolic and diastolic blood pressure. "
06/01/1985 - "However, in sham-operated animals, ICI 118551 attenuated the development of hypertension and significantly reduced neurogenic pressor responses in the subsequently pithed rats. "
|7.||Adrenergic Receptors (Adrenergic Receptor)